Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 57 results:
[ Author] Title Type Year Filters: Author is Tziomalos, Konstantinos [Clear All Filters]
Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome..
Hum Reprod. 28(3), 785-93.
(2013). Left ventricular hypertrophy assessed by electrocardiogram is associated with more severe stroke and with higher in-hospital mortality in patients with acute ischemic stroke..
Atherosclerosis. 274, 206-211.
(2018). Type 2 diabetes is associated with a worse functional outcome of ischemic stroke..
World J Diabetes. 5(6), 939-44.
(2014). Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke..
Blood Coagul Fibrinolysis. 27(2), 185-9.
(2016). The use of sibutramine in the management of obesity and related disorders: an update..
Vasc Health Risk Manag. 5(1), 441-52.
(2009). Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B..
World J Hepatol. 2(3), 91-3.
(2010). Barriers to insulin treatment in patients with type 2 diabetes mellitus..
Expert Opin Pharmacother. 18(3), 233-234.
(2017). Predictive value of the ankle brachial index in patients with acute ischemic stroke..
Vasa. 43(1), 55-61.
(2014). Response to "Brachial Systolic Blood Pressure Fails to Predict Short-Term Outcome in Patients With Acute Ischemic Stroke: What About Central Systolic Pressure?"..
Am J Hypertens. 28(9), 1181.
(2015). JUPITER: major implications for vascular risk assessment..
Curr Med Res Opin. 25(1), 133-7.
(2009). Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients..
Mediators Inflamm. 2010, 364957.
(2010). Unresolved issues in lipid-lowering treatment..
Panminerva Med. 58(2), 191-5.
(2016). Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension..
Curr Pharm Des. 19(21), 3766-72.
(2013). Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome..
Front Endocrinol (Lausanne). 9, 149.
(2018). Lipid-lowering agents in the management of nonalcoholic fatty liver disease..
World J Hepatol. 6(10), 738-44.
(2014). Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke..
Atherosclerosis. 243(1), 65-70.
(2015). Lipoprotein a: where are we now?.
Curr Opin Cardiol. 24(4), 351-7.
(2009). Combination treatment in HBeAg-negative chronic hepatitis B..
World J Hepatol. 1(1), 43-7.
(2009). High-density lipoprotein: quantity or quality?.
J Thorac Dis. 8(11), 2975-2977.
(2016). Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome..
World J Hepatol. 5(11), 621-6.
(2013). Omega-3 fatty acids: how can they be used in secondary prevention?.
Curr Atheroscler Rep. 10(6), 510-7.
(2008). Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke..
J Clin Hypertens (Greenwich). 17(4), 275-80.
(2015). Anti-inflammatory effects of fibrates: an overview..
Curr Med Chem. 16(6), 676-84.
(2009). Treatment of congenital fibrinogen deficiency: overview and recent findings..
Vasc Health Risk Manag. 5, 843-8.
(2009). Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs..
Curr Vasc Pharmacol. 14(2), 208-10.
(2016).